GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Konruns Pharmaceutical Co Ltd (SHSE:603590) » Definitions » Cyclically Adjusted PS Ratio

Beijing Konruns Pharmaceutical Co (SHSE:603590) Cyclically Adjusted PS Ratio : 5.51 (As of May. 15, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Beijing Konruns Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-05-15), Beijing Konruns Pharmaceutical Co's current share price is ¥30.28. Beijing Konruns Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was ¥5.50. Beijing Konruns Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 5.51.

The historical rank and industry rank for Beijing Konruns Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHSE:603590' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.64   Med: 5.58   Max: 6.66
Current: 5.77

During the past 11 years, Beijing Konruns Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 6.66. The lowest was 4.64. And the median was 5.58.

SHSE:603590's Cyclically Adjusted PS Ratio is ranked worse than
51.07% of 513 companies
in the Biotechnology industry
Industry Median: 5.58 vs SHSE:603590: 5.77

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Beijing Konruns Pharmaceutical Co's adjusted revenue per share data of for the fiscal year that ended in Dec23 was ¥5.870. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥5.50 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Beijing Konruns Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Beijing Konruns Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Konruns Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Beijing Konruns Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 4.52 6.92

Beijing Konruns Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 6.92 -

Competitive Comparison of Beijing Konruns Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Beijing Konruns Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Konruns Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Konruns Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Beijing Konruns Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Beijing Konruns Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Beijing Konruns Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=30.28/5.5
=5.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Konruns Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Beijing Konruns Pharmaceutical Co's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=5.87/114.6694*114.6694
=5.870

Current CPI (Dec23) = 114.6694.

Beijing Konruns Pharmaceutical Co Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 4.550 99.000 5.270
201512 3.641 100.600 4.150
201612 2.890 102.600 3.230
201712 4.921 104.500 5.400
201812 7.668 106.500 8.256
201912 6.650 111.200 6.857
202012 5.072 111.500 5.216
202112 5.144 113.108 5.215
202212 5.551 115.116 5.529
202312 5.870 114.669 5.870

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Beijing Konruns Pharmaceutical Co  (SHSE:603590) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Beijing Konruns Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Beijing Konruns Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Konruns Pharmaceutical Co (SHSE:603590) Business Description

Traded in Other Exchanges
N/A
Address
No. 11 Xingsheng South Road, Economic Development Zone, Miyun District, Beijing, CHN
Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of innovative drugs, and is oriented to clinical needs.

Beijing Konruns Pharmaceutical Co (SHSE:603590) Headlines

No Headlines